MODULATORS OF MULTIDRUG-RESISTANCE - PRECLINICAL STUDIES

被引：92
作者：
FORD, JM
机构：
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 1995年 / 9卷 / 02期
关键词：
D O I：
10.1016/S0889-8588(18)30098-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Numerous compounds have been identified that sensitize multidrug-resistant cells to chemotherapeutic drugs in experimental systems. The mechanism of activity of these pharmacologic agents, termed chemosensitizers, appears to be mediated through direct inhibition of the drug efflux activity of the MDR1 gene product, P-glycoprotein. This article describes commonly used experimental models for the discovery and preclinical evaluation of new chemosensitizers, reviews those agents that possess potential for clinical use to circumvent multidrug resistance in humans, and discusses strategies to identify novel drugs of this type with improved efficacy and reduced toxicity.
引用
收藏
页码：337 / 361
页数：25
相关论文
共 132 条
[71]   CELL-SURFACE P-GLYCOPROTEIN ASSOCIATED WITH MULTIDRUG RESISTANCE IN MAMMALIAN-CELL LINES [J].
KARTNER, N ;
RIORDAN, JR ;
LING, V .
SCIENCE, 1983, 221 (4617) :1285-1288
[72]   RESISTANCE TO TETRACYCLINE, A HYDROPHILIC ANTIBIOTIC, IS MEDIATED BY P-GLYCOPROTEIN IN HUMAN MULTIDRUG-RESISTANT CELLS [J].
KAVALLARIS, M ;
MADAFIGLIO, J ;
NORRIS, MD ;
HABER, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 190 (01) :79-85
[73]  
KESSEL D, 1985, CANCER TREAT REP, V69, P673
[74]  
KESSEL D, 1985, CANCER RES, V45, P1687
[75]  
KLOPMAN G, 1992, CANCER RES, V52, P4121
[76]  
LEONESSA F, 1994, CANCER RES, V54, P441
[77]  
LOO TW, 1994, J BIOL CHEM, V269, P7243
[78]   SDZ-280-446, A NOVEL SEMISYNTHETIC CYCLOPEPTOLIDE - INVITRO AND INVIVO CIRCUMVENTION OF THE P-GLYCOPROTEIN-MEDIATED TUMOR-CELL MULTIDRUG RESISTANCE [J].
LOOR, F ;
BOESCH, D ;
GAVERIAUX, C ;
JACHEZ, B ;
POURTIERMANZANEDO, A ;
EMMER, G .
BRITISH JOURNAL OF CANCER, 1992, 65 (01) :11-18
[79]  
LUM BL, 1993, CANCER, V72, P3502, DOI 10.1002/1097-0142(19931201)72:11+<3502::AID-CNCR2820721618>3.0.CO
[80]  
2-N
3456789101112